These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 30288957)

  • 1. Filamin-A as a Balance between Erk/Smad Activities During Cardiac Valve Development.
    Toomer K; Sauls K; Fulmer D; Guo L; Moore K; Glover J; Stairley R; Bischoff J; Levine RA; Norris RA
    Anat Rec (Hoboken); 2019 Jan; 302(1):117-124. PubMed ID: 30288957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental basis for filamin-A-associated myxomatous mitral valve disease.
    Sauls K; de Vlaming A; Harris BS; Williams K; Wessels A; Levine RA; Slaugenhaupt SA; Goodwin RL; Pavone LM; Merot J; Schott JJ; Le Tourneau T; Dix T; Jesinkey S; Feng Y; Walsh C; Zhou B; Baldwin S; Markwald RR; Norris RA
    Cardiovasc Res; 2012 Oct; 96(1):109-19. PubMed ID: 22843703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Periostin/Filamin-A: A Candidate Central Regulatory Axis for Valve Fibrogenesis and Matrix Compaction.
    Misra S; Ghatak S; Moreno-Rodriguez RA; Norris RA; Hascall VC; Markwald RR
    Front Cell Dev Biol; 2021; 9():649862. PubMed ID: 34150753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human myxomatous mitral valve prolapse: role of bone morphogenetic protein 4 in valvular interstitial cell activation.
    Sainger R; Grau JB; Branchetti E; Poggio P; Seefried WF; Field BC; Acker MA; Gorman RC; Gorman JH; Hargrove CW; Bavaria JE; Ferrari G
    J Cell Physiol; 2012 Jun; 227(6):2595-604. PubMed ID: 22105615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-β signalling and reactive oxygen species drive fibrosis and matrix remodelling in myxomatous mitral valves.
    Hagler MA; Hadley TM; Zhang H; Mehra K; Roos CM; Schaff HV; Suri RM; Miller JD
    Cardiovasc Res; 2013 Jul; 99(1):175-84. PubMed ID: 23554457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights into mitral valve dystrophy: a Filamin-A genotype-phenotype and outcome study.
    Le Tourneau T; Le Scouarnec S; Cueff C; Bernstein D; Aalberts JJJ; Lecointe S; Mérot J; Bernstein JA; Oomen T; Dina C; Karakachoff M; Desal H; Al Habash O; Delling FN; Capoulade R; Suurmeijer AJH; Milan D; Norris RA; Markwald R; Aikawa E; Slaugenhaupt SA; Jeunemaitre X; Hagège A; Roussel JC; Trochu JN; Levine RA; Kyndt F; Probst V; Le Marec H; Schott JJ
    Eur Heart J; 2018 Apr; 39(15):1269-1277. PubMed ID: 29020406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening of TGFBR1, TGFBR2, and FLNA in familial mitral valve prolapse.
    Aalberts JJ; van Tintelen JP; Oomen T; Bergman JE; Halley DJ; Jongbloed JD; Suurmeijer AJ; van den Berg MP
    Am J Med Genet A; 2014 Jan; 164A(1):113-9. PubMed ID: 24243761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of Axin2 results in impaired heart valve maturation and subsequent myxomatous valve disease.
    Hulin A; Moore V; James JM; Yutzey KE
    Cardiovasc Res; 2017 Jan; 113(1):40-51. PubMed ID: 28069701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased Infiltration of Extra-Cardiac Cells in Myxomatous Valve Disease.
    Sauls K; Toomer K; Williams K; Johnson AJ; Markwald RR; Hajdu Z; Norris RA
    J Cardiovasc Dev Dis; 2015 Sep; 2(3):200-213. PubMed ID: 26473162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodality imaging and transcriptomics to phenotype mitral valve dystrophy in a unique knock-in Filamin-A rat model.
    Delwarde C; Toquet C; Aumond P; Kayvanjoo AH; Foucal A; Le Vely B; Baudic M; Lauzier B; Blandin S; Véziers J; Paul-Gilloteaux P; Lecointe S; Baron E; Massaiu I; Poggio P; Rémy S; Anegon I; Le Marec H; Monassier L; Schott JJ; Mass E; Barc J; Le Tourneau T; Merot J; Capoulade R
    Cardiovasc Res; 2023 May; 119(3):759-771. PubMed ID: 36001550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MVP-Associated Filamin A Mutations Affect FlnA-PTPN12 (PTP-PEST) Interactions.
    Duval D; Labbé P; Bureau L; Le Tourneau T; Norris RA; Markwald RR; Levine R; Schott JJ; Mérot J
    J Cardiovasc Dev Dis; 2015 Sep; 2(3):233-247. PubMed ID: 26594644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Filamin-a-related myxomatous mitral valve dystrophy: genetic, echocardiographic and functional aspects.
    Lardeux A; Kyndt F; Lecointe S; Marec HL; Merot J; Schott JJ; Le Tourneau T; Probst V
    J Cardiovasc Transl Res; 2011 Dec; 4(6):748-56. PubMed ID: 21773876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary cilia defects causing mitral valve prolapse.
    Toomer KA; Yu M; Fulmer D; Guo L; Moore KS; Moore R; Drayton KD; Glover J; Peterson N; Ramos-Ortiz S; Drohan A; Catching BJ; Stairley R; Wessels A; Lipschutz JH; Delling FN; Jeunemaitre X; Dina C; Collins RL; Brand H; Talkowski ME; Del Monte F; Mukherjee R; Awgulewitsch A; Body S; Hardiman G; Hazard ES; da Silveira WA; Wang B; Leyne M; Durst R; Markwald RR; Le Scouarnec S; Hagege A; Le Tourneau T; Kohl P; Rog-Zielinska EA; Ellinor PT; Levine RA; Milan DJ; Schott JJ; Bouatia-Naji N; Slaugenhaupt SA; Norris RA
    Sci Transl Med; 2019 May; 11(493):. PubMed ID: 31118289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the Interleukin-33/ST2 Pathway Exerts Deleterious Effects in Myxomatous Mitral Valve Disease.
    Garcia-Pena A; Ibarrola J; Navarro A; Sadaba A; Tiraplegui C; Garaikoetxea M; Arrieta V; Matilla L; Fernández-Celis A; Sadaba R; Alvarez V; Gainza A; Jover E; López-Andrés N
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-syndromic Mitral Valve Dysplasia Mutation Changes the Force Resilience and Interaction of Human Filamin A.
    Haataja TJK; Bernardi RC; Lecointe S; Capoulade R; Merot J; Pentikäinen U
    Structure; 2019 Jan; 27(1):102-112.e4. PubMed ID: 30344108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging pathogenic mechanisms in human myxomatous mitral valve: lessons from past and novel data.
    Hulin A; Deroanne C; Lambert C; Defraigne JO; Nusgens B; Radermecker M; Colige A
    Cardiovasc Pathol; 2013; 22(4):245-50. PubMed ID: 23261354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical Structural Defects Explain Filamin A Mutations Causing Mitral Valve Dysplasia.
    Haataja TJK; Capoulade R; Lecointe S; Hellman M; Merot J; Permi P; Pentikäinen U
    Biophys J; 2019 Oct; 117(8):1467-1475. PubMed ID: 31542223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGF-beta1 pathway activation and adherens junction molecular pattern in nonsyndromic mitral valve prolapse.
    Rizzo S; Basso C; Lazzarini E; Celeghin R; Paolin A; Gerosa G; Valente M; Thiene G; Pilichou K
    Cardiovasc Pathol; 2015; 24(6):359-67. PubMed ID: 26345253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Losartan inhibits endothelial-to-mesenchymal transformation in mitral valve endothelial cells by blocking transforming growth factor-β-induced phosphorylation of ERK.
    Wylie-Sears J; Levine RA; Bischoff J
    Biochem Biophys Res Commun; 2014 Apr; 446(4):870-5. PubMed ID: 24632204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desert hedgehog-primary cilia cross talk shapes mitral valve tissue by organizing smooth muscle actin.
    Fulmer D; Toomer KA; Glover J; Guo L; Moore K; Moore R; Stairley R; Gensemer C; Abrol S; Rumph MK; Emetu F; Lipschutz JH; McDowell C; Bian J; Wang C; Beck T; Wessels A; Renault MA; Norris RA
    Dev Biol; 2020 Jul; 463(1):26-38. PubMed ID: 32151560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.